aripiprazole and Autism
aripiprazole has been researched along with Autism in 34 studies
Research
Studies (34)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (23.53) | 29.6817 |
2010's | 22 (64.71) | 24.3611 |
2020's | 4 (11.76) | 2.80 |
Authors
Authors | Studies |
---|---|
Pierce, DL; Smith, JR | 1 |
Naguy, A; Naguy, C | 1 |
Alamiri, B; Hasan, AE; Jamali, MA; Naguy, A; Pridmore, S | 1 |
Aboul-Fotouh, S; El-Salam, MFA; Elayat, WM; Elhossiny, RM; Habib, MZ; Hassan, GAM; Mohamad, MI; Zohny, SM | 1 |
Fatima, S; Mottola, N | 1 |
Tang, J; Xie, Q; Xu, Y; Zeng, HL | 1 |
Berk, M; Ghanizadeh, A; Sahraeizadeh, A | 1 |
Forbes, RA; Mankoski, R; Manos, G; Marcus, R; Marler, S; McQuade, R; Stockton, G | 1 |
Anagnostou, E; Baribeau, DA | 1 |
Amatniek, J; Eudicone, JM; Findling, RL; Lears, K; Mankoski, R; Marcus, RN; McCartney, T; McQuade, RD; Sheehan, JJ; Timko, K | 1 |
Adler, BA; Early, M; Erickson, CA; McDougle, CJ; Minshawi, N; Shaffer, R; Wink, LK | 1 |
Bent, S; Hendren, RL | 1 |
Karakurt, MN; Süren, S | 1 |
Ghanizadeh, A; Jaafari, N; Tordjman, S | 1 |
DeFilippis, M; Wagner, KD | 1 |
Sanchack, KE; Thomas, CA | 1 |
Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
Cosenza, A; Masi, G; Millepiedi, S; Muratori, F; Pari, C; Salvadori, F | 1 |
De León, OA; Garza, VM; Shepherd, J | 1 |
Aman, MG; Carson, WH; Kamen, L; Manos, G; Marcus, RN; McQuade, RD; Owen, R | 1 |
Carson, WH; Corey-Lisle, P; Findling, RL; Manos, G; Marcus, RN; McQuade, RD; Owen, R; Sikich, L | 1 |
Aman, MG; Kasper, W; Mankoski, R; Manos, G; Marcus, R; Mathew, S; Owen, R | 1 |
Gialloreti, LE; Guida, S; Pardini, M | 1 |
Aman, MG; Farmer, CA | 1 |
Curran, MP | 2 |
Aman, MG; Carson, WH; Corey-Lisle, PK; Kamen, L; Mankoski, R; Manos, G; Marcus, RN; McQuade, RD; Owen, R | 1 |
Carson, WH; Findling, RL; Kamen, L; Mankoski, R; Manos, G; Marcus, RN; McQuade, RD; Owen, R | 1 |
Ammerman, DK; Carson, WH; Corey-Lisle, PK; Guo, Z; Handen, BL; Mankoski, R; Manos, G; Marcus, RN; Mathew, S; McQuade, RD; Owen, R; Varni, JW | 1 |
Kirino, E | 1 |
Eisenstein, M | 1 |
Tsai, SJ | 1 |
Alla, L; Sabaratnam, M; Shastri, M | 1 |
Demb, H; Valicenti-McDermott, MR | 1 |
Reviews
8 review(s) available for aripiprazole and Autism
Article | Year |
---|---|
An update on medication management of behavioral disorders in autism.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Humans; Piperazines; Propylamines; Quinolones; Risperidone | 2014 |
Complementary and alternative treatments for autism part 1: evidence-supported treatments.
Topics: Acetylcysteine; Animals; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Complementary Therapies; Disease Models, Animal; Evidence-Based Medicine; Free Radical Scavengers; Gastrointestinal Tract; Humans; Inflammation; Mice; Oxidative Stress; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration; Vitamin B 12 | 2015 |
Aripiprazole for treating irritability in children & adolescents with autism: A systematic review.
Topics: Adolescent; Aripiprazole; Autistic Disorder; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Randomized Controlled Trials as Topic | 2015 |
Autism Spectrum Disorder: Primary Care Principles.
Topics: Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Autism Spectrum Disorder; Autistic Disorder; Behavior Therapy; Child Development Disorders, Pervasive; Child, Preschool; Early Diagnosis; Early Medical Intervention; Humans; Infant; Primary Health Care; Referral and Consultation; Risperidone | 2016 |
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2008 |
Aripiprazole for the treatment of irritability associated with autism.
Topics: Antipsychotic Agents; Aripiprazole; Autistic Disorder; Humans; Irritable Mood; Piperazines; Quinolones; Risperidone | 2011 |
Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.
Topics: Aripiprazole; Autistic Disorder; Child; Clinical Trials as Topic; Drug Dosage Calculations; Humans; Irritable Mood; Piperazines; Quinolones; Time Factors | 2011 |
Efficacy and safety of aripiprazole in child and adolescent patients.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Bipolar Disorder; Child; Humans; Piperazines; Quinolones; Schizophrenia | 2012 |
Trials
8 trial(s) available for aripiprazole and Autism
Article | Year |
---|---|
A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Risperidone; Treatment Outcome | 2014 |
Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Body Weight; Child; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones | 2013 |
A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Double-Blind Method; Drug Administration Schedule; Female; Humans; Irritable Mood; Kaplan-Meier Estimate; Long-Term Care; Male; Piperazines; Placebos; Quinolones; Secondary Prevention; Treatment Outcome | 2014 |
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Irritable Mood; Male; Personality Assessment; Piperazines; Psychomotor Agitation; Quinolones; Self-Injurious Behavior; Treatment Outcome | 2009 |
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Personality Assessment; Piperazines; Quinolones; Treatment Outcome; Weight Gain | 2009 |
Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
Topics: Adolescent; Affective Symptoms; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Checklist; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Self-Injurious Behavior; Treatment Outcome | 2010 |
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Female; Follow-Up Studies; Humans; Irritable Mood; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2011 |
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
Topics: Adolescent; Aggression; Alanine Transaminase; Antipsychotic Agents; Aripiprazole; Aspartate Aminotransferases; Autistic Disorder; Basal Ganglia Diseases; Child; Drug Tolerance; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Weight Gain | 2011 |
Other Studies
18 other study(ies) available for aripiprazole and Autism
Article | Year |
---|---|
Topics: Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Compulsive Behavior; Humans; Sexual Behavior | 2022 |
Trichotieromania and Alopecia Areata Triggered by Aripiprazole-Methylphenidate Combo in an Autistic Child: The Nexus of Impulsivity-Compulsivity.
Topics: Alopecia Areata; Aripiprazole; Autistic Disorder; Child; Humans; Impulsive Behavior; Methylphenidate | 2022 |
Agomelatine Monotherapy for Autism-A Case Report.
Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Humans; Risperidone | 2022 |
Memantine/Aripiprazole Combination Alleviates Cognitive Dysfunction in Valproic Acid Rat Model of Autism: Hippocampal CREB/BDNF Signaling and Glutamate Homeostasis.
Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Homeostasis; Male; Memantine; Pregnancy; Rats; Rats, Wistar; Valproic Acid | 2023 |
Case 5: A 7-year-old Autistic Boy with Altered Movements and Mental Status.
Topics: Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Dystonia; Humans; Male | 2017 |
[Clinical observation of aripiprazole in the treatment of autism].
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child, Preschool; Female; Humans; Male; Piperazines; Quinolones | 2013 |
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Intellectual Disability; Male; Middle Aged; Pilot Projects; Piperazines; Quinolones; Retrospective Studies; Risk Factors; Risperidone; Self-Injurious Behavior; Treatment Failure; Young Adult | 2015 |
Desmopressin Use in the Treatment of Aripiprazole-Induced Nocturnal Enuresis in a Child Diagnosed with Autıstıc Disorder.
Topics: Antidiuretic Agents; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Deamino Arginine Vasopressin; Humans; Male; Nocturnal Enuresis | 2015 |
Treatment of Autism Spectrum Disorder in Children and Adolescents.
Topics: Adolescent; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Child; Humans; Irritable Mood; Risperidone; Serotonin Antagonists | 2016 |
Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Chi-Square Distribution; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Severity of Illness Index | 2009 |
Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder.
Topics: Adult; Aripiprazole; Autistic Disorder; Bipolar Disorder; Catatonia; Humans; Male; Piperazines; Quinolones | 2009 |
Aripiprazole treatment for coprophagia in autistic disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Human Coprophagia; Humans; Male; Piperazines; Quinolones | 2010 |
Aripiprazole in the treatment of irritability associated with autistic disorder in paediatric patients: profile report.
Topics: Adolescent; Aripiprazole; Autistic Disorder; Child; Double-Blind Method; Humans; Irritable Mood; Piperazines; Quinolones; Randomized Controlled Trials as Topic | 2011 |
Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Dose-Response Relationship, Drug; Humans; Irritable Mood; Piperazines; Quality of Life; Quinolones; Randomized Controlled Trials as Topic | 2012 |
Treatments: In the waiting room.
Topics: Adolescent; Adult; Animals; Aripiprazole; Autistic Disorder; Brain; Child; Clinical Trials as Topic; Drug Approval; Drug Repositioning; Humans; Oxytocin; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Trichuris; United States; United States Food and Drug Administration | 2012 |
TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism.
Topics: Aripiprazole; Autistic Disorder; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Epilepsy; Humans; Piperazines; Quinolones; Receptor, trkB; Signal Transduction | 2006 |
Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.
Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Female; Humans; Intellectual Disability; Male; Mental Disorders; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenia, Paranoid | 2006 |
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders | 2006 |